Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.340

-0.060 (-4.29%)

At close: Jun 13, 2025, 4:00 PM

1.330

-0.010 (-0.74%)

After-hours: Jun 13, 2025, 7:07 PM EDT

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $293.10 million as of June 13, 2025. Its market cap has decreased by -39.75% in one year.

Market Cap

293.10M

Enterprise Value

101.98M

1-Year Change

-39.75%

Ranking

#3380

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $293.10M, a decrease of -89.83%. That is a compound annual growth rate of -28.98%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	293.10M	-34.37%
Dec 31, 2024	446.60M	-17.32%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	3.54B	11.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	735.57B
Johnson & Johnson	377.99B
Novo Nordisk	355.28B
AbbVie	337.52B
UnitedHealth Group	284.42B
Abbott Laboratories	235.96B
Novartis AG	234.52B
AstraZeneca	231.58B

Market Cap Rankings